December 3, 2021
HELSINKI, Finland -- Euformatics, Finnish bioinformatics software company, has today announced that its genomic variant interpretation and reporting tool, omnomicsNGS, has been granted the CE-IVD mark under the In-Vitro Diagnostics Directive (98/79/EC). The software, previously a CE-marked medical device class I under preceding EU legislation, is now making strong progress on its journey to being [...]
ATS Completes Acquisition of SP Industries
December 3, 2021
CAMBRIDGE, ON - ATS Automation Tooling Systems Inc. (TSX: ATA) ("ATS" or the "Company"), an industry-leading automation solutions provider, today announced the successful completion of its acquisition of SP Industries, Inc. ("SP"), a designer and manufacturer of high-grade biopharma processing equipment, life sciences equipment, and lab apparatus products. ATS entered into a definitive agreement and [...]
December 2, 2021
BOULDER, Colo. -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that Steve Mermelstein joined the company as Senior Vice President of Corporate Strategy, Development and Mergers and Acquisitions (M&A). “We are thrilled to welcome Steve to the SomaLogic team,” said SomaLogic Chief Executive Officer Roy Smythe, M.D. “His extensive advisory and [...]
Thomas Scientific Finalizes Supplier Agreement with City and County of San Francisco
December 2, 2021
It’s the second significant award in a month for North America’s largest pure-play distributor serving science, building off what has been a strong 2021. SWEDESBORO, NEW JERSEY and SAN FRANCISCO, CALIFORNIA – In its second notable contract award over the past four weeks, Thomas Scientific has entered into a 5-year agreement with the City and County [...]
December 2, 2021
Next Generation Sequencing Software to Help Antibody Engineers, Bioinformaticians Uncover Potential Antibody Therapeutics SANTA FE, N.M. – OpenEye Scientific and Specifica, Inc., today announced they are releasing jointly developed software to help antibody engineers and bioinformaticians at pharmaceutical and biotechnology companies advance antibody discovery by identifying diverse antibody sets with better properties for downstream therapeutics [...]
New Wastewater Diagnostic Kit for SARS-CoV-2 Testing including Identification of Omicron Variant
December 2, 2021
SARS-CoV-2 Testing including Identification of Omicron Variant December 02, 2021 Eurofins Technologies announces the launch of the VIRSeek SARS-CoV-2 Mplex I and Mplex II Wastewater real-time RT-PCR kits to provide an efficient solution for SARS-CoV-2 detection in wastewater, including the Omicron variant of concern. Wastewater-based epidemiology has become an important approach in order to comprehensively monitor the profile [...]
Meridian Bioscience Announces Retirement of CFO Bryan Baldasare
December 2, 2021
CINCINNATI -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that Bryan Baldasare, Executive Vice President, Chief Financial Officer, and Secretary, will retire from Meridian effective December 31, 2021. The Company is engaging an executive search firm in the recruitment of a new [...]
December 2, 2021
EMERYVILLE, Calif. and MARSEILLE, France -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and MImAbs SAS, an emerging CRO that discovers and develops antibodies for immunotechnology therapeutics and research, today announced the acquisition of the Berkeley Lights Beacon® system via a TechAccess subscription to help further its mission of helping its customers [...]
PacBio Names Jason Kang as Vice President and General Manager for Asia-Pacific Region
December 1, 2021
Strategic hire will expand Company’s commercial presence in key geography MENLO PARK, Calif. — PacBio (NASDAQ:PACB), a leading provider of high-quality, long-read sequencing platforms, welcomes Jason Kang as Vice President and General Manager for the company’s Asia-Pacific region. Jason will be responsible for leading and developing PacBio’s commercial team in Asia-Pacific as the company continues to expand its reach in the [...]
BD Issues 2021 Global Inclusion, Diversity and Equity Report
December 1, 2021
Progress Builds Strong Foundation for Bold 2030+ ESG Goals to Advance the World of Health for All FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the release of its 2021 Global Inclusion, Diversity and Equity (ID&E) Report. The report, titled "Together We Advance ID&E," [...]

